Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa C Rohan

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
AIDS and Behavior|May 27, 2014
Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectallyAlex Carballo-Diéguez, Rebecca Giguere, Curtis Dolezal, et al.
American Journal of Pharmaceutical Education|April 27, 2011
Core competencies for research training in the clinical pharmaceutical sciencesSamuel M Poloyac, Kerry M Empey, Lisa C Rohan, et al.
AAPS Pharmscitech|February 24, 2021
Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV PreventionLindsay F Kramzer, Krystal T Hamorsky, Phillip W Graebing, et al.
AIDS Research and Human Retroviruses|November 5, 2016
Comparison of Dapivirine Vaginal Gel and Film Formulation Pharmacokinetics and Pharmacodynamics (FAME 02B)Jennifer A Robinson, Mark A Marzinke, Rahul P Bakshi, et al.
Plos One|November 13, 2012
Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityCharlene S Dezzutti, Elizabeth R Brown, Bernard Moncla, et al.
ACS Infectious Diseases|September 6, 2018
Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral SusceptibilitySujeethraj Koppolu, Linlin Wang, Ayushi Mathur, et al.
International Journal of Pharmaceutics|January 24, 2021
Biorelevant and screening dissolution methods for minocycline hydrochloride microspheres intended for periodontal administrationSravan Kumar Patel, Ashlee C Greene, Stuti M Desai, et al.
Scientific Reports|May 10, 2023
A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4<sup>+</sup> cell distribution in the human rectal mucosaMathias Franzén Boger, Nora Benhach, Tyra Hasselrot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2015
A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal FilmKatherine E Bunge, Charlene S Dezzutti, Lisa C Rohan, et al.
JCI Insight|December 8, 2022
Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaquesPeng Xiao, Sanjeev Gumber, Mark A Marzinke, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
AIDS and Behavior|May 27, 2014
Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectallyAlex Carballo-Diéguez, Rebecca Giguere, Curtis Dolezal, et al.
American Journal of Pharmaceutical Education|April 27, 2011
Core competencies for research training in the clinical pharmaceutical sciencesSamuel M Poloyac, Kerry M Empey, Lisa C Rohan, et al.
AAPS Pharmscitech|February 24, 2021
Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV PreventionLindsay F Kramzer, Krystal T Hamorsky, Phillip W Graebing, et al.
AIDS Research and Human Retroviruses|November 5, 2016
Comparison of Dapivirine Vaginal Gel and Film Formulation Pharmacokinetics and Pharmacodynamics (FAME 02B)Jennifer A Robinson, Mark A Marzinke, Rahul P Bakshi, et al.
Plos One|November 13, 2012
Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityCharlene S Dezzutti, Elizabeth R Brown, Bernard Moncla, et al.
ACS Infectious Diseases|September 6, 2018
Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral SusceptibilitySujeethraj Koppolu, Linlin Wang, Ayushi Mathur, et al.
International Journal of Pharmaceutics|January 24, 2021
Biorelevant and screening dissolution methods for minocycline hydrochloride microspheres intended for periodontal administrationSravan Kumar Patel, Ashlee C Greene, Stuti M Desai, et al.
Scientific Reports|May 10, 2023
A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4<sup>+</sup> cell distribution in the human rectal mucosaMathias Franzén Boger, Nora Benhach, Tyra Hasselrot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2015
A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal FilmKatherine E Bunge, Charlene S Dezzutti, Lisa C Rohan, et al.
JCI Insight|December 8, 2022
Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaquesPeng Xiao, Sanjeev Gumber, Mark A Marzinke, et al.
Pageof 9